MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • All Meetings
    • 2026 International Congress
  • Keyword Index
  • Resources
  • Advanced Search
  • 2026 International Congress

    Underestimation of Nighttime Sleep Symptoms in Isolated RBD is Associated with Increased Risk of Phenoconversion to Synucleinopathy: A North American Prodromal Synucleinopathy Consortium Study

    J. Ha, D. Bliwise, H. Dela Cruz, C. Xiong, T. Ferman, K. Kantarci, V. Lowe, S. Criswell, E. ST. Louis, D. Huddleston, A. Avidan, Y. Ju, M. Lim, M. Miglis, R. Postuma, A. Videnovic, B. Boeve, M. Howell, L. Trotti (Atlanta, USA)

    Objective: To determine whether mismatch between participant (PT) self-perceived and bed partner (BP)–reported sleep symptoms is associated with risk of phenoconversion to synucleinopathy. Background: Patients…
  • 2026 International Congress

    Electrophysiological Signatures of Peak Tremor Frequency Differentiate Parkinson’s Disease, Essential Tremor, and Dystonic Tremor: A Three-Way Comparative Study

    V. Thi Hinh, V. Hoang Yen, N. Hai Yen, T. Hue Linh, N. van Lieu (Hanoi, Viet Nam)

    Objective: To define disease-specific tremor frequency and oscillatory signatures across Parkinson’s disease (PD), essential tremor (ET), and dystonic tremor (DT) and assess their diagnostic utility.…
  • 2026 International Congress

    Diagnosis and therapeutic approaches for sialorrhea in patients with Parkinson’s disease.

    N. Fedotova, E. Bril, O. Turgunkhujaev, O. Zimnyakova (Moscow, Russian Federation)

    Objective: To study the frequency of drooling complaints in Parkinson's disease (PD) patients during outpatient visits. Background: Sialorrhea (excessive drooling) is a non-motor symptom of…
  • 2026 International Congress

    Real-world database analysis of new-onset hypotension and medications for orthostatic hypotension prescribing patterns in patients with Parkinson’s Disease receiving MAO-B Inhibitors and levodopa in Japan

    M. Nagai, R. Ando, K. Sasaki, Y. Tomita, K. Daidoji, Y. Kogo, T. Ishida (Ehime, Japan)

    Objective: To evaluate the incidence of claims-defined new-onset hypotension and the prescribing patterns of medications for orthostatic hypotension in patients with Parkinson’s disease (PD) treated…
  • 2026 International Congress

    Pregnancy and Breastfeeding in Early-Onset Parkinson’s Disease:Therapeutic Challenges of Levodopa Monotherapy.A case Report.

    K. Salinas-Barboza, J. Altamirano, L. Salinas-Yañez, D. Avecilla-Bonilla (CDMX, Mexico)

    Objective: To describe the clinical course and treatment challenges of early-onset Parkinson’s disease (EOPD) during pregnancy and breastfeeding Background: Parkinson’s disease (PD) is rare in…
  • 2026 International Congress

    THD (Tyrosine Hydroxylase Deficiency) in a 39-Year-Old Woman with Early-Onset Dystonia

    T. Le (Dallas, USA)

    Objective: To report a case of tyrosine hydroxylase deficiency (THD), a rare neurometabolic disorder that disrupts catecholamine biosynthesis. This case report highlights common neurologic abnormalities,…
  • 2026 International Congress

    Immune-mediated Chorea in Antiphospholipid Syndrome: Normalization of FDG-PET and Neurofilament as Markers of Treatment Response.

    L. Peraferrer-Montesinos, J. Martínez-Rodríguez, A. Fernández-Lebrero, M. Viles-Garcia, E. Carrillo Villamizar, P. Plaza-López, V. Puente-Periz, I. Navalpotro-Gómez (Barcelona, Spain)

    Objective: To present a case where FDG-PET and neurofilament findings help portray the reversibility of neuronal damage in antiphospholipid syndrome (aPL).   Background: Chorea is the most common movement disorder in aPL and often an initial manifestation, although…
  • 2026 International Congress

    Military-related associations with Parkinson’s disease (PD) in the Millenium Cohort Study

    S. Goldman, E. Richard, R. Rull, E. Boyko, K. Friedl, E. Hu, L. Liu, S. Boparai, N. Riedel, K. Comyns, E. Brown, C. Tanner (San Francisco, USA)

    Objective: To examine associations between military-related exposures and PD. Background: The Millennium Cohort Study is a large prospective cohort of 260,228 US service members and…
  • 2026 International Congress

    Digital Health, Telemedicine, and Artificial Intelligence in Parkinson’s Disease Management During COVID-19: A Narrative Review

    H. Harifi (Kenitra, Morocco)

    Objective: The objective of this narrative review was to evaluate the effectiveness of telemedicine and AI-based technologies used for the remote monitoring and management of…
  • 2026 International Congress

    Changes in Continuous Good ON and Best ON Time During the Waking Day With Tavapadon in People With Parkinson’s Disease

    R. Hauser, R. Dhall, D. Kremens, L. Harmer, K. Chan, J. Ma (Tampa, USA)

    Objective: To evaluate motor states throughout the waking day when tavapadon is added to oral carbidopa/levodopa in adults with Parkinson’s disease (PD) experiencing motor fluctuations.…
  • « Previous Page
  • 1
  • …
  • 14
  • 15
  • 16
  • 17
  • 18
  • …
  • 1942
  • Next Page »

Related Sites

International Parkinson and Movement Disorder Society

The Society that manages the annual International Congress »

International Congress

The official website for the International Congress of Parkinson’s and Movement Disorders® »

  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2026 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley